Research Focus

Former Employee. Human Resources; TES Employee

Recent additions – View all

1. A phase II study of topotecan administered five times daily in patients with advanced gastric cancer

   Journal Article

   Saltz, L. B.; Schwartz, G. K.; Ilson, D. H.; Quan, V.; Kelsen, D. P.
   American Journal of Clinical Oncology (1997)

   Fulltext@MSK | Save
2. Neoadjuvant therapy of high-risk gastric cancer: A phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

   Journal Article

   Kelsen, D.; Karpeh, M.; Schwartz, G.; Gerdes, H.; Lightdale, C.; Botet, J.; Lauers, G.; Klimstra, D.; Huang, Y.; Saltz, L.; more...
   Journal of Clinical Oncology (1996)

   Fulltext@MSK | Save
3. A Phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil + doxorubicin + high dose methotrexate + leucovorin) with oral uridine rescue

   Journal Article

   Schwartz, G. K.; Christman, K.; Saltz, L.; Casper, E.; Quan, V.; Bertino, J.; Martin, D. S.; Colofiore, J.; Kelsen, D.
   Cancer (1996)

   Fulltext@MSK | Save